.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Teva
Federal Trade Commission
Citi
Express Scripts
Farmers Insurance
UBS
Covington
Healthtrust
Deloitte

Generated: November 20, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN GLARGINE; LIXISENATIDE

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi-aventis Us
SOLIQUA 100/33
insulin glargine; lixisenatide
SOLUTION;SUBCUTANEOUS208673NDASanofi-Aventis U.S. LLC0024-5761-055 SYRINGE in 1 CARTON (0024-5761-05) > 3 mL in 1 SYRINGE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
UBS
Chinese Patent Office
Farmers Insurance
Deloitte
Cantor Fitzgerald
Daiichi Sankyo
Julphar
McKinsey
US Army

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot